Kira Dies, ScM, CGC
Study Operations Director
Boston Children's Hospital (BCH)
Ms. Dies received her ScM in Genetic Counseling in 2003 from a joint program through Johns Hopkins Bloomberg School of Public Health and the National Human Genome Research Institute. She is a board certified and licensed genetic counselor in Massachusetts. She has worked in various roles at Boston Children’s Hospital (BCH), including Senior Genetic Counseling Program Manager and Co-Director of Clinical Research Operations of the Translational Neuroscience Center. In January 2021, she was named Executive Director of the new Rosamund Stone Zander and Hansjoerg Wyss Translational Neuroscience Center at BCH.
In 2024, Ms. Dies completed a fellowship in bioethics at the Harvard Medical School Center for Bioethics. She is an Ethics Associate on the Ethics Advisory Committee and an Affiliate of the HMS Center for Bioethics. Additionally, she is a clinical instructor at the Boston University School of Medicine Genetic Counseling Graduate Program where she co-teaches the ethics curriculum. She is also a faculty member of the Boston Leadership Education in Neurodevelopmental and related Disabilities (LEND) Program.
In addition, she serves on the Board of Directors for the CureAP4 hereditary spastic paraplegia patient advocacy organization. She is on the Board of Directors and serves as Treasurer for New England Regional Genetics Group (NERGG). She co-directs the Research Subcommittee of the Neuroscience Family Advisory Council at BCH. She also volunteers as an activity coordinator for Special Olympics in Massachusetts.